| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. (REGN) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 46 sells. REGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 310.5K | $189.36M | - | |
| CEO | 214.5K | $130.85M | - | |
| VP | 47.8K | $29.18M | - | |
| VP | 29.5K | $18.00M | - | |
| VP | 21.7K | $13.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2023 | Goldstein Joseph L | Director | Sale+OE | 3,613 | $800.00 | $2,890,400.00 | -36.6% | -3.7% | +20.1% | |
| Feb 6, 2023 | Brown Michael S49 | Director | Sale+OE | 3,571 | $797.86 | $2,849,158.00 | -32.5% | -3.7% | +20.1% | |
| Feb 6, 2023 | Yancopoulos George50 | President And Chief Scientific | Sell | 13,189 | $800.08 | $10,552,255.12 | -6.2% | -3.7% | +20.1% | |
| Feb 6, 2023 | Landry Robert E52 | EVP Finance CFO | Sale+OE | 1,491 | $776.80 | $1,158,203.66 | -0.3% | -3.7% | +20.1% | |
| Feb 3, 2023 | Bassler Bonnie L59 | Director | Sale+OE | 1,021 | $779.00 | $795,359.00 | -45.0% | -3.7% | +20.7% | |
| Feb 1, 2023 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,100 | $752.19 | $827,409.00 | -4.7% | +5.3% | +26.4% | |
| Feb 1, 2023 | Ryan Arthur F54 | Director | Sell | 100 | $756.13 | $75,613.49 | - | +5.3% | +26.4% | |
| Jan 27, 2023 | Brown Michael S49 | Director | Sale+OE | 1 | $747.00 | $747.00 | - | +6.7% | +26.5% | |
| Jan 6, 2023 | Brown Michael S49 | Director | Sale+OE | 3,070 | $747.14 | $2,293,719.80 | -71.1% | +12.4% | +23.9% | |
| Jan 3, 2023 | Ryan Arthur F54 | Director | Sell | 100 | $726.29 | $72,628.79 | - | +14.7% | +27.4% |